Skip to content

Lab quality diabetes testing, at home.

Home testing services for the detection of diabetes.

Lab quality diabetes testing, at home.

Home testing services for the detection of diabetes.

HubSpot Video

Timely Diabetes Care Demands a New Approach to Testing

Half of all adults currently living with diabetes remain undiagnosed. Given the significant population health implications of missed or delayed detection, an immediate step-change is required in how we test for diabetes.

Digostics' revolutionary new testing platforms offer the world's first and only alternative to in-clinic testing for glucose intolerance by enabling the oral glucose tolerance test (OGTT) to be performed at home. 

Simplified testing.  Increased patient throughput.  Better outcomes. 

HubSpot Video

Timely Diabetes Care Demands a New Approach to Testing

Half of all adults currently living with diabetes remain undiagnosed. Given the significant population health implications of missed or delayed detection, an immediate step-change is required in how we test for diabetes.

Digostics' revolutionary new testing platforms offer the world's first and only alternative to in-clinic testing for glucose intolerance by enabling the oral glucose tolerance test (OGTT) to be performed at home. 

Simplified testing.  Increased patient throughput.  Better outcomes. 

Introducing innovative OGTT home testing platforms designed to support the timely and accurate detection of all types of diabetes.

Introducing innovative OGTT home testing platforms designed to support the timely and accurate detection of all types of diabetes.

Home Testing for Early Diabetes Detection

Digostics' home testing platforms ensure more patients can be easily tested, on time.

Our platforms offer the same level of accuracy as clinic tests but without any of the staffing requirements, risks of sample degradation and laboratory delays that often impact clinic testing capacity.

By removing the need for in-clinic tests, we provide a gateway to more extensive testing, faster results and unparalleled opportunities for earlier clinical intervention.

Demonstration: Patient Using Test a GTT@home Test Device
Demonstration: Patient Using Test a GTT@home Test Device

Home Testing for Early Diabetes Detection

Digostics' home testing platforms ensure more patients can be easily tested, on time.

Our platforms offer the same level of accuracy as clinic tests but without any of the staffing requirements, risks of sample degradation and laboratory delays that often impact clinic testing capacity.

By removing the need for in-clinic tests, we provide a gateway to more extensive testing, faster results, and unparalleled opportunities for earlier clinical intervention.

  • 100% focus on diabetes

  • Cutting-edge testing platforms

  • Pioneers of accurate home testing

  • Introduced the world's first home OGTT

  • Leaders in patient-centred design

  • Open architecture and system interoperability

  • 100% focus on diabetes

  • Cutting-edge testing platforms

  • Pioneers of accurate home testing

  • Introduced the world's first home OGTT

  • Leaders in patient-centred design

  • Open architecture and system interoperability

 "OGTTs are an important but inaccessible test.  However, Digostics' OGTT home-testing approach could change this by making the detection of prediabetes, GDM and diabetes convenient and easy to perform."

Professor Stephen Colagiuri

Image of Professor Stephen Colagiuri
The University of Sydney logo

 "OGTTs are an important but inaccessible test.  However, Digostics' OGTT home testing approach could change this by making the detection of prediabetes, GDM and diabetes convenient and easy to perform."

Professor Stephen Colagiuri

An headshot image of Professor Stephen Colagiuri of University of Sydney
The University of Sydney logo
A picture of a mother and young child with diabetes in discussion with a doctor.

100% Focus on Diabetes

Digostics create and deliver class-leading test and service platforms that enable the early identification of diabetes through efficient screening of at-risk individuals.

With the support of leading clinical advisors and academic partners, we are proud to offer groundbreaking solutions that push the boundaries of what is achievable in diabetes detection.

Gestational Diabetes

Gestational Diabetes

Type One

Type One

Type Two

Type Two

Prediabetes

Prediabetes

A picture of a mother and young child with diabetes in discussion with a doctor.

100% Focus on Diabetes

We create and deliver class-leading test and service platforms that enable the early identification of diabetes through efficient screening of at-risk individuals.

With the support of leading clinical advisors and academic partners, we are proud to offer groundbreaking solutions that push the boundaries of what is achievable in diabetes detection.

Gestational Diabetes

Gestational Diabetes

Type One

Type One

Type Two

Type Two

Prediabetes

Prediabetes

Digostics' Partners in Diabetes Innovation

 
 
 
Panel only seen by widget owner

Leaders in Remote Diabetes Testing

Digostics uses advanced wireless and sensor technologies to enable safe and secure diabetes testing at home.

We ensure that a greater number of patients can be screened for diabetes without compromising test accuracy or adding to the burden of overworked clinical care teams.

GTT@home is Digostics' breakthrough solution and the world's first and only home OGTT, conveniently providing clinic-equivalent test results.

An image of the GTT@home logo
An image of the GTT@home solution-as-a-service test kits, mobile application and test scheduling and review software.

Leaders in Remote Diabetes Testing

Digostics uses advanced wireless and sensor technologies to enable safe and secure diabetes testing at home.

We ensure that a greater number of patients can be screened for diabetes without compromising test accuracy or adding to the burden of overworked clinical care teams.

GTT@home is Digostics' breakthrough solution and the world's first and only home OGTT, conveniently providing clinic-equivalent test results.

An image of the GTT@home solution-as-a-service test kits, mobile application and test scheduling and review software.
An image of the GTT@home logo

Click to learn more about GTT@home

Demonstration: An image of a user interacting with the GTT@home mobile application.

Patient-Centric Design and Human Factors

Unlocking the full population health potential of diabetes screening at home requires the elimination of all procedural complexities, allowing patients to complete their tests confidently without the need for clinical assistance.

With our deep expertise in human factors and by thorough extensive user testing and refinement, Digostics ensures that our diabetes home testing solutions are as convenient and effortless to use as they are accurate.
 

Patient-Centric Design and Human Factors

Unlocking the full population health potential of diabetes screening at home requires the elimination of all procedural complexities, allowing patients to complete their tests confidently without the need for clinical assistance.

With our deep expertise in human factors and by thorough extensive user testing and refinement, Digostics ensures that our diabetes home testing solutions are as convenient and effortless to use as they are accurate.
 

Demonstration: An image of a user interacting with the GTT@home mobile application.

Download the Digostics Company Datasheet

An image of two clinical researchers analysing GTT@home clinical data

Empowering Clinical Research

Digostics' cutting-edge diagnostic platforms allow clinical researchers to access at speed and scale tests that were previously a major barrier to achieving breakthroughs.  

We are adding new test and service elements to our platforms to empower researchers by easing patient recruitment, boosting compliance, reducing clinic visits and enriching datasets.

Open Architecture and System Interoperability

Digostics is a strong advocate of interoperability.  That's why all our diabetes testing platforms are built with an open architecture and adhere to the HL7 FHIR standards.

Clinical users have the freedom to perform a range of tasks, from scheduling tests to analysing data, securely and conveniently within our software.  Alternatively, they can draw on our API and productised integrations to undertake the same activity from within their preferred adjacent hospital systems.

An image of the Digostics test scheduling and review portal, and HCP support site.
The HL7 FHIR logo.
HCP Support Architecture 2-2-2-2-2
The HL7 FHIR logo.

Open Architecture and System Interoperability

Digostics is a strong advocate of interoperability.  That's why all our diabetes testing platforms are built with an open architecture and adhere to the HL7 FHIR standards.

Clinical users have the freedom to perform a range of tasks, from scheduling tests to analysing data, securely and conveniently within our software.  Alternatively, they can draw on our API and productised integrations to undertake the same activity from within their preferred adjacent hospital system.

An image of two clinical researchers analysing GTT@home clinical data

Empowering Clinical Research

Digostics' cutting-edge diagnostic platforms allow clinical researchers to access at speed and scale tests that were previously a major barrier to achieving breakthroughs.  

We are adding new test and service elements to our platforms to empower researchers by easing patient recruitment, boosting compliance, reducing clinic visits and enriching datasets.

Digostics in the News

 
 
 
Panel only seen by widget owner

Download the Digostics Company Overview

Click the button to register to download a datasheet providing Digostics company information and introducing our ground-breaking work in diabetes home testing.

Could GTT@home be of assistance to your patients?

Please get in touch by completing the form below or calling Digostics on +44 (0)330 113 9145